[ad_1]
(MedPage Today) — For a balloon-expandable transcatheter aortic valve replacement (TAVR or TAVI) platform, the much-litigated Myval performed well enough in the COMPARE-TAVI 1 randomized trial, but its rates of pacemakers and paravalvular leaks…
[ad_2]
Source link : https://www.medpagetoday.com/cardiology/pci/114984
Author :
Publish date : 2025-04-04 21:44:00
Copyright for syndicated content belongs to the linked Source.
Embattled TAVR Device Myval Meets Expectations in Trial, but Trouble Still Ahead
Related Posts
